Helga S. Alig
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Toxicity-over-time analysis of anti-EGFR-based maintenance versus stop&go in left-sided, RAS/BRAF wild-type metastatic colorectal cancer.
Journal: Journal of the National Cancer Institute
Published: February 19, 2026
Pancreatic Cancer Highlights from the European Society for Medical Oncology Annual Meeting 2024 in Barcelona.
Journal: Oncology research and treatment
Published: June 10, 2025
Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti-EGFR-Based Maintenance for RAS wt Metastatic CRC-The PanaMa (AIO KRK0212) Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2025
Primary tumor sidedness and negative hyperselection to modulate anti-EGFR-based maintenance strategies in patients with RAS wild-type metastatic colorectal cancer: individual patient data pooled analysis of two randomized clinical trials.
Journal: British journal of cancer
Published: January 05, 2025
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2024.
Journal: Oncology research and treatment
Published: December 15, 2024
Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116).
Journal: Journal of cancer research and clinical oncology
Published: April 02, 2024
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023.
Journal: Oncology research and treatment
Published: December 20, 2023
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 04, 2023
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 05, 2023
Follow-up lung ultrasound to monitor lung failure in COVID-19 ICU patients.
Journal: PloS one
Published: January 16, 2022
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Journal: Frontiers in oncology
Published: August 01, 2021
Last Updated: 09/26/2026